TAGLIAFERRI MARY
SEC insider (Form 3/4/5 filer). CIK 0001323304. Director at Iambic Therapeutics, Inc. (IAM) and 1 other issuer. 1 reported Form 4/5 transaction since Sep 2024; latest on Oct 14, 2026. Located in SAN DIEGO, CA.
Companies TAGLIAFERRI MARY has filed insider reports for
- Iambic Therapeutics, Inc. (IAM): Director
- ADARx Pharmaceuticals, Inc. (ADRX): Director
TAGLIAFERRI MARY
CIK: 0001323304
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
